(Q37961619)

26 August 2017

Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up? (English)

1 reference

26 August 2017

S M Hosseini-Moghaddam

1

1 reference

26 August 2017

E Iran-Pour

2

1 reference

26 August 2017

C Rotstein

3

1 reference

26 August 2017

S Husain

4

1 reference

26 August 2017

L Lilly

5

1 reference

26 August 2017

E Renner

6

1 reference

26 August 2017

T Mazzulli

7

1 reference

26 August 2017

24 November 2011

1 reference

Reviews in Medical Virology

26 August 2017

1 reference

26 August 2017

22

1 reference

26 August 2017

3

1 reference

26 August 2017

156-165

1 reference

A chemiluminescent, magnetic particle-based immunoassay for the detection of hepatitis C virus core antigen in human serum or plasma

26 August 2017

1 reference

Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response

21 January 2018

1 reference

Distribution of hepatitis C virus genotypes in the Middle East

21 January 2018

1 reference

Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362].

21 January 2018

1 reference

Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)

21 January 2018

1 reference

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

21 January 2018

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa

21 January 2018

1 reference

Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins

21 January 2018

1 reference

Performance Characteristics of a Quantitative, Homogeneous TaqMan RT-PCR Test for HCV RNA

21 January 2018

1 reference

Hepatitis C virus infection

21 January 2018

1 reference

Dynamics of viremia in early hepatitis C virus infection

21 January 2018

1 reference

Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users

21 January 2018

1 reference

Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies

21 January 2018

1 reference

Hepatitis C virus six years on.

21 January 2018

1 reference

Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.

21 January 2018

1 reference

Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapy.

21 January 2018

1 reference

Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes

21 January 2018

1 reference

Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay

21 January 2018

1 reference

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

21 January 2018

1 reference

Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection

21 January 2018

1 reference

Efficacy of HCV core antigen detection during the preseroconversion period

21 January 2018

1 reference

Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen

21 January 2018

1 reference

Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations

21 January 2018

1 reference

Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection

21 January 2018

1 reference

Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China

21 January 2018

1 reference

Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals

21 January 2018

1 reference

Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan

21 January 2018

1 reference

High stability of enzyme immunoassay for hepatitis C virus core antigen-evaluation before and after incubation at room temperature

21 January 2018

1 reference

Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection

21 January 2018

1 reference

Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?

21 January 2018

1 reference

Hepatitis C core antigen in Polish blood donors.

21 January 2018

1 reference

Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.

21 January 2018

1 reference

Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay

21 January 2018

1 reference

Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals

21 January 2018

1 reference

Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA).

21 January 2018

1 reference

Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis C

21 January 2018

1 reference

Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors

21 January 2018

1 reference

Performance of an automated system for quantitation of hepatitis C virus core antigen

21 January 2018

1 reference

Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy

21 January 2018

1 reference

Combination HCV core antigen and antibody assay on a fully automated chemiluminescence analyzer

21 January 2018

1 reference

HCV core antigen as an alternative to NAT to detect HCV viremia

21 January 2018

1 reference

Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time.

21 January 2018

1 reference

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin

21 January 2018

1 reference

Financial impact of two different ways of evaluating early virological response to peginterferon-alpha-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1.

21 January 2018

1 reference

Comparative Evaluation of the Total Hepatitis C Virus Core Antigen, Branched-DNA, and Amplicor Monitor Assays in Determining Viremia for Patients with Chronic Hepatitis C during Interferon Plus Ribavirin Combination Therapy

21 January 2018

1 reference

A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection

21 January 2018

1 reference

Monitoring Response to Antiviral Therapy for Patients with Chronic Hepatitis C Virus Infection by a Core-Antigen Assay

21 January 2018

1 reference

Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems

21 January 2018

1 reference

Clinical usefulness of total hepatitis C virus core antigen quantification to monitor the response to treatment with peginterferon alpha-2a plus ribavirin*.

21 January 2018

1 reference

The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment

21 January 2018

1 reference

The role of core antigen detection in management of hepatitis C: a critical review.

21 January 2018

1 reference

Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy

21 January 2018

1 reference

Evaluation of clinical usefulness of second-generation HCV core antigen assay: comparison with COBAS AMPLICOR HCV MONITOR assay version 2.0.

21 January 2018

1 reference

Significance of the hepatitis C virus (HCV) core antigen as an alternative plasma marker of active HCV infection

21 January 2018

1 reference

New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification.

21 January 2018

1 reference

Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin

21 January 2018

1 reference

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

21 January 2018

1 reference

Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors.

21 January 2018

1 reference

Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients

21 January 2018

1 reference

Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy

21 January 2018

1 reference

Usefulness of the Hepatitis C Virus Core Antigen Assay for Screening of a Population Undergoing Routine Medical Checkup

21 January 2018

1 reference

Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States

21 January 2018

1 reference

Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen

21 January 2018

1 reference

High HCV prevalence in Egyptian blood donors

21 January 2018

1 reference

Hepatitis C infection and the patient with end-stage renal disease

21 January 2018

1 reference

Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.

21 January 2018

1 reference

Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease?

21 January 2018

1 reference

Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.

21 January 2018

1 reference

Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients

21 January 2018

1 reference

Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis

21 January 2018

1 reference

Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients

21 January 2018

1 reference

Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities.

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection

21 January 2018

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal control

21 January 2018

1 reference

Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment

21 January 2018

1 reference

Dynamics of hepatitis C viremia following interferon-alpha administration

21 January 2018

1 reference

Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay

21 January 2018

1 reference

Comparative study of conventional and novel strategies for the detection of hepatitis C virus RNA in serum: amplicor, branched-DNA, NASBA and in-house PCR.

21 January 2018

1 reference

Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.717

1 reference

26 August 2017

1 reference